Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Current Challenges in the Pharmaceutical Industry and AI's Role in Addressing Them
1
Zitationen
7
Autoren
2025
Jahr
Abstract
The pharmaceutical industry is facing a range of challenges, including skyrocketing drug development costs, inefficiencies in clinical trials, supply chain disruptions, stringent quality control standards, and the complex world of marketing and sales. This is where artificial intelligence (AI) steps in, acting as a game-changer by addressing these hurdles with cutting-edge tools like computer-assisted drug design (CADD), predictive modeling, and data analytics. This chapter delves into how AI-driven solutions are boosting the speed, accuracy, and efficiency of pharmaceutical operations, while also recognizing the hurdles posed by inconsistent data, intellectual property issues, and ethical concerns. A thorough look at AI's role in pharmaceutical companies reveals its benefits, drawbacks, and future possibilities, all while stressing the importance of ethical considerations and the need for regulatory flexibility to fully harness AI's groundbreaking potential.
Ähnliche Arbeiten
A short history of<i>SHELX</i>
2007 · 86.913 Zit.
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
2009 · 35.509 Zit.
[20] Processing of X-ray diffraction data collected in oscillation mode
1997 · 33.530 Zit.
A new and rapid colorimetric determination of acetylcholinesterase activity
1961 · 26.634 Zit.
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
2009 · 24.061 Zit.